Publicacións en colaboración con investigadores/as de Universitat de Barcelona (106)

2024

  1. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

    Nutrition Journal, Vol. 23, Núm. 1

2023

  1. Anandamide and 2-arachidonoylglycerol baseline plasma concentrations and their clinical correlate in gambling disorder

    European Psychiatry, Vol. 66, Núm. 1

  2. Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity

    European Psychiatry, Vol. 66, Núm. 1

  3. Exploring the influence of circulating endocannabinoids and nucleus accumbens functional connectivity on anorexia nervosa severity

    Molecular Psychiatry

2022

  1. Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

    Acta Neuropathologica, Vol. 144, Núm. 2, pp. 241-258

  2. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome

    eLife, Vol. 11

  3. Correction: Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial (International Journal of Behavioral Nutrition and Physical Activity, (2022), 19, 1, (101), 10.1186/s12966-022-01335-8)

    International Journal of Behavioral Nutrition and Physical Activity

  4. Effects of Mixing Energy Drinks With Alcohol on Driving-Related Skills

    The international journal of neuropsychopharmacology, Vol. 25, Núm. 1, pp. 13-25

  5. Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions

    Journal of Clinical Medicine, Vol. 11, Núm. 12

  6. Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial

    International Journal of Behavioral Nutrition and Physical Activity, Vol. 19, Núm. 1

  7. Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience

    Biomedicine and Pharmacotherapy, Vol. 149

  8. Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)

    Genetics in Medicine, Vol. 24, Núm. 10, pp. 2004-2013

  9. Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome

    Frontiers in Nutrition, Vol. 9

  10. Transcriptional response to a Mediterranean diet intervention exerts a modulatory effect on neuroinflammation signaling pathway

    Nutritional Neuroscience, Vol. 25, Núm. 2, pp. 256-265

  11. Vitamin K dietary intake is associated with cognitive function in an older adult Mediterranean population

    Age and ageing, Vol. 51, Núm. 2

2021

  1. Effects of a psychosocial intervention at one-year follow-up in a PREDIMED-plus sample with obesity and metabolic syndrome

    Scientific Reports, Vol. 11, Núm. 1

  2. Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases

    World Allergy Organization Journal, Vol. 14, Núm. 1

  3. Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study

    Frontiers in Endocrinology, Vol. 12

  4. Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome

    Scientific Reports, Vol. 11, Núm. 1

  5. Interplay between cognition and weight reduction in individuals following a Mediterranean Diet: Three-year follow-up of the PREDIMED-Plus trial

    Clinical Nutrition, Vol. 40, Núm. 9, pp. 5221-5237